Amh Equity LTD Harvard Bioscience Inc Put Options Transaction History
Amh Equity LTD
- $91.4 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
98Shares Held
31.2MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$3.84 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$3.72 Million0.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$3.62 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$2.91 Million0.0% of portfolio
-
Royce & Associates LP1.97MShares$2.65 Million0.04% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $56.2M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...